PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.

Francesco FiciElif Ari BakirElif Ilkay YüceSerdal KanuncuWim MakelBahar Arican TarimNicolas Roberto Robles

Published in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2020)

The treatments decrease the prevalence of subjects with albuminuria, showing a significant difference among the different drug combinations, favoring the use of new dihydropyridine calcium channel blockers, such as lercanidipine, combined with RAAS inhibitors, to control albuminuria in diabetic hypertensive patients.

Keyphrases

hypertensive patients
blood pressure
chronic kidney disease
type diabetes
wound healing
end stage renal disease
risk factors
high intensity
cross sectional
emergency department
angiotensin converting enzyme
drug induced
angiotensin ii